Sera Prognostics, Inc. (SERA)
NASDAQ: SERA · Real-Time Price · USD
3.350
+0.130 (4.04%)
At close: Oct 23, 2025, 4:00 PM EDT
3.350
0.00 (0.00%)
After-hours: Oct 23, 2025, 4:00 PM EDT
Sera Prognostics Market Cap
Sera Prognostics has a market cap or net worth of $127.51 million as of October 23, 2025. Its market cap has decreased by -47.00% in one year.
Market Cap
127.51M
Enterprise Value
17.44M
1-Year Change
-47.00%
Ranking
Category
Stock Price
$3.35
Market Cap Chart
Since the IPO on July 15, 2021, Sera Prognostics's market cap has decreased from $488.14M to $127.51M, a decrease of -73.88%. That is a compound annual growth rate of -26.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2025 | 127.89M | -53.48% |
| Dec 31, 2024 | 274.91M | 46.70% |
| Dec 29, 2023 | 187.39M | 379.49% |
| Dec 30, 2022 | 39.08M | -81.47% |
| Dec 31, 2021 | 210.90M | -56.79% |
| Jul 15, 2021 | 488.14M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 717.80B |
| Johnson & Johnson | 462.11B |
| AbbVie | 408.76B |
| UnitedHealth Group | 330.91B |
| AstraZeneca | 259.08B |
| Novartis AG | 254.71B |
| Novo Nordisk | 245.28B |
| Abbott Laboratories | 221.98B |